ReproGo develops precision-engineered human cells, including iPSC-derived RCells™, for biomedical research and drug discovery. Their AI-powered platform rapidly creates specific human cell types to model various disease states. The company focuses on creating cell-based therapies aimed at restoring blood vessel function to treat incurable vascular diseases.
Funding
$460K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many severe and life-threatening conditions result from the deterioration or loss of blood vessels, leading to impaired blood flow and tissue damage. Current treatments often focus on managing symptoms rather than restoring vascular function. Developing effective therapies for these incurable conditions and disabilities remains a significant challenge.
Solution
ReproGo is a biotechnology company specializing in regenerative medicine and vascular diseases, offering therapies designed to restore blood vessel function. Their approach involves creating precision-engineered human induced pluripotent stem cell (iPSC)-derived cells, termed RCells™, using an AI-powered platform. These cells can be programmed to become any human cell type with high speed, accuracy, and reliability. The company is developing therapeutics that utilize these cells to facilitate the restoration of blood vessel function in any organ or tissue, aiming to prevent rather than just treat vascular-related conditions.
Target Audience
The primary target audience includes researchers and drug discovery companies seeking precision-engineered human cells, as well as patients suffering from incurable conditions and disabilities resulting from the deterioration or loss of blood vessels.
Features
- AI-powered platform for creating precision-engineered human iPSC-derived cells (RCells™)
- Ability to craft any human cell type with high speed, accuracy, and reliability
- Therapeutics focused on restoring blood vessel function in various organs and tissues
- Potential for multiple treatments derived from the created cells